Eden Research plc Notice of Results (1808M)
May 06 2020 - 12:09PM
UK Regulatory
TIDMEDEN
RNS Number : 1808M
Eden Research plc
06 May 2020
6 May 2020
Eden Research Plc
("Eden" or "Company")
Notice of Results
Eden Research plc (AIM: EDEN), the AIM-quoted company focused on
sustainable biopesticides for use in global crop protection, animal
health and consumer products industries, announces that its
preliminary results for the period ending 30 December 2019 will be
issued on Thursday 7 May 2020.
The results will be published at 07.00 (BST) through the
regulatory news service (RNS) and on the company's website (
https://www.edenresearch.com/ ).
For further information contact:
Eden Research plc www.edenresearch.com
Sean Smith
Alex Abrey 01285 359 555
Cenkos Securities plc (Nominated advisor
and broker)
Giles Balleny / Cameron MacRitchie (corporate
finance)
Michael Johnson (sales) 020 7397 8900
Hawthorn Advisors (Financial PR)
Lorna Cobbett eden@hawthornadvisors.com
Jana Tsiligiannis
Ed Curtis
Notes:
Eden Research is an AIM-quoted company that develops and
supplies breakthrough biopesticide products and natural
microencapsulation technologies to the global crop protection,
animal health and consumer products industries.
Eden's Sustaine ä encapsulation technology harnesses the
biocidal efficacy of naturally occurring chemicals produced by
plants (terpenes) and can be used with both natural and synthetic
compounds to enhance their performance and ease-of-use.
Sustaine microcapsules are naturally derived, plastic-free,
biodegradable micro-spheres derived from yeast extract. They
produce stabilised aqueous suspensions which are easy to mix and
apply, have phased release patterns, are safer for the environment
and the crops themselves.
The European Chemicals Agency (ECHA) has proposed an EU-wide
restriction on the placing on the market or use of
"intentionally-added" microplastic particles. The proposed
restriction includes the use of microplastics for agricultural and
horticultural purposes, including polymers utilized for
controlled-release fertilizers, encapsulated plant protection
products (PPP's), seed coatings, and biocides.
By 2025 in the EU, pesticides containing synthetic polymer
microplastics are likely to be banned or removed from the market.
The only acceptable alternative is the substitution with
biodegradable formulations. Reformulated products will need to be
evaluated and registered within the five-year transition
period.
Sustaine is one of the only viable, proven and immediately
registerable solutions to the microplastics problem in formulations
requiring encapsulation.
Historically, terpenes have had limited commercial use in the
agrochemical sector due to their volatility, phytotoxicity and poor
solubility. Sustaine provides a unique, environmentally friendly
solution to these problems and enables terpenes to be used as
effective, low-risk agrochemicals.
Eden is developing these technologies through innovative
research and a series of commercial production, marketing and
distribution partnerships.
The Company has a number of patents and a pipeline of products
at differing stages of development targeting specific areas of the
global agrochemicals industry. To date, the Company has invested in
the region of GBP14m in developing and protecting its intellectual
property and seeking regulatory approval for products that rely
upon the Company's technologies. Revenues earned by the Company
have been modest whilst the Company has concentrated on securing
patent protection for its intellectual property, gaining regulatory
approvals, identifying suitable industrial partners, and entering
into commercial agreements.
In May 2013, the three actives that comprise Eden's first
commercial product, Mevalone, were approved as new ingredients for
use in plant protection products by the European Commission ("EC").
This represented a major milestone in the commercialisation of
Eden's technology and is a significant accomplishment for any
company. To illustrate this point, one should note that in 2013,
Eden's approvals represented 3 of only 10 new active ingredients
approved by the EC.
Mevalone ä is a foliar fungicide which has been authorised for
sale in Kenya, Malta, Greece,
Bulgaria, Spain, Italy, France, Cyprus, Albania , Portugal and Macedonia.
Cedroz(TM) ä is a nematicide which has been authorised for sale
in Malta, Belgium and Mexico.
Eden was admitted to trading on AIM on 11 May 2012 and trades
under the symbol EDEN.
For more information about Eden, please visit:
www.edenresearch.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORFLFIREDIRIII
(END) Dow Jones Newswires
May 06, 2020 12:09 ET (16:09 GMT)
Eden Research (AQSE:EDEN.GB)
Historical Stock Chart
From Jun 2024 to Jul 2024
Eden Research (AQSE:EDEN.GB)
Historical Stock Chart
From Jul 2023 to Jul 2024